Seeking Alpha

The aesthetic devices market is seeing various technological advancements leading to high functionality, lower costs, and ease of operation. The emergence of minimally invasive and non-invasive aesthetic procedures is fueling the growth of this market. Cynosure (CYNO), a leading player in this market, hasn't seen much activity in its stock in 2013. The stock has traded between a 52-week low of $21.09 and a 52-week high of $30.20. Currently it is trading around $26. The company's EPS is expected to rise more than 50% next year. Its recent acquisition of Palomar Medical Technologies is expected to result in $8 million to $10 million cost synergies in 2014. I feel that the stock is a good bargain at the...

Only subscribers can access this article, which is part of the PRO research library covering 3,770 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: